US 6376483
Bacteriochlorins and bacteriopurpurins useful as photoselective compounds for photodynamic therapy and a process for their production
expired A61KA61K41/0057A61K41/0071
Quick answer
US patent 6376483 (Bacteriochlorins and bacteriopurpurins useful as photoselective compounds for photodynamic therapy and a process for their production) held by Miravant Pharmaceuticals, Inc. expires Mon Apr 18 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- Miravant Pharmaceuticals, Inc.
- Grant date
- Tue Apr 23 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 18 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K41/0057, A61K41/0071, A61P, A61P35/00